New Consumer Goods market report from Euromonitor International: "Digestive Remedies in the US"
Boston, MA -- (SBWIRE) -- 06/13/2014 -- According to a survey conducted by Johnson & Johnson in the United Arab Emirates which has subsequently been published in the public domain, nearly one person in four in the country seeks no treatment whatsoever when experiencing digestive problems such as diarrhoea as they believe that the symptoms are not severe enough to warrant medical intervention or because they mistakenly believe that diarrhoea is the body's natural way of purging itself of toxins. It is interesting to note that many people in the United Arab Emirates have stated that they would not seek treatment for their digestive ailments even when their problems persist for over one month. In addition, according to numerous nutritionists, many people in the United Arab Emirates have accepted that they suffer from frequent headaches, feel bloated, have low energy levels and suffer from acidity problems after eating. Heartburn and constipation were also reported as very common problems among the United Arab Emirates population during 2013, a situation which is due mainly to the high fat content of the average diet in the United Arab Emirates as well as dehydration and a general lack of physical activity.
View Full Report Details and Table of Contents
GlaxoSmithKline Plc led digestive remedies in 2013 with a 19% value share. The company achieved this position through its high brand equity and the popularity of Zantac, its leading digestive remedies brand. Sanofi-Aventis and Reckitt Benckiser followed in second and third positions respectively with similar value shares thanks to the company's globally famous brands Maalox and Gaviscon. These companies are able to leverage on their global popularity as well as high levels of investment in advertising.
It is unlikely that the common trend of not treating digestive problems will change substantially in the United Arab Emirates during the forecast period as this is a deeply cultural ingrained behaviour. Nevertheless, as the government of the United Arab Emirates engages in attempts to boost awareness of the importance of curing digestive symptoms, it is possible that an increasing number of the United Arab Emirates' consumers will seek the advice of pharmacists when they experiencing digestive issues.
Discover the latest market trends and uncover sources of future market growth for the Digestive Remedies industry in United Arab Emirates with research from Euromonitor's team of in-country analysts.
Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.
If you're in the Digestive Remedies industry in United Arab Emirates, our research will save you time and money while empowering you to make informed, profitable decisions.
About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.
Browse all Consumer Goods research reports at Fast Market Research
You may also be interested in these related reports:
- Digestive Remedies in Israel
- Digestive Remedies in the United Kingdom
- Digestive Remedies in South Korea
- Digestive Remedies in Ukraine
- Digestive Remedies in the United Arab Emirates
- Digestive Remedies in Bosnia-Herzegovina
- Digestive Remedies in Hungary
- Digestive Remedies in Ireland
- Digestive Remedies in India
- Digestive Remedies in Indonesia